Keeping Track: Clovis Completes NDA; FDA Clears 3D-Printed Antiepileptic But Declines Preservative-Free Eye Drug

 
• By Bridget Silverman

The latest drug development news and highlights from our FDA Performance Tracker.

More from Archive

More from Pink Sheet